dallas semaglutide constipation lawsuit SURGE IN GLP-1 DRUGS LIKE OZEMPIC SPARKS THOUSANDS OF LAWSUITS OVER ALLEGED SIDE EFFECTS The medications, initially for type 2 diabetes, have driven widespread off-label weight-loss use amid reported gastrointestinal injuries and Dallas - SURGE IN GLP-1
Description
Every state has been wrestling with it, every professional association that my staff is a part of has had some discussion about it, Sam Watts, director of SHP, said in an interview
Rushing dose increases often leads to intolerable side effects that may cause patients to stop treatment prematurely

The drugs prescription targets individuals with a body mass index (BMI) of 27 kg/m2 or higher, who suffer from at least one weight-related ailment, or those with a BMI of 30 kg/m2 or higher

If you have lingering gastrointestinal side effects, consider waiting to increase the dose, or increasing the dosage more slowly

Instead, try grilling, broiling, or air-frying
